0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
If approved, ZyCov-D will be the world’s first DNA vaccine, with 'primary efficacy' of 66.6%, against infection with SARS-CoV-2.
Share this article
If you liked this article share it with your friends.they will thank you later